ダウンロード数: 317

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
31_2090.pdf2.05 MBAdobe PDF見る/開く
タイトル: 淋菌性感染症の疫学的治療学的研究 --Aztreonamによるone shot療法の検討--
その他のタイトル: Epidemiologic and therapeutic study on gonorrheal infections--one shot therapy by aztreonam
著者: 熊本, 悦明  KAKEN_name
酒井, 茂  KAKEN_name
玉手, 広時  KAKEN_name
郷路, 勉  KAKEN_name
猪野毛, 健男  KAKEN_name
田端, 重男  KAKEN_name
丹田, 均  KAKEN_name
加藤, 修爾  KAKEN_name
井川, 欣市  KAKEN_name
田付, 二郎  KAKEN_name
辺見, 泉  KAKEN_name
生垣, 舜二  KAKEN_name
吉尾, 弘  KAKEN_name
上野, 了  KAKEN_name
出口, 浩一  KAKEN_name
著者名の別形: KUMAMOTO, Yoshiaki
SAKAI, Shigeru
TAMATE, Hirotoki
GOHRO, Tsutomu
INOKE, Takeo
TABATA, Shigeo
TANDA, Hitoshi
KATO, Shuji
IGAWA, Kinichi
TAZUKI, Jiro
HENMI, Izumi
IKEGAKI, Shunji
YOSHIO, Hiroshi
UENO, Tooru
DEGUCHI, Kohichi
キーワード: STD
Gonorrheal infections
Aztreonam
One shot therapy
発行日: Nov-1985
出版者: 泌尿器科紀要刊行会
誌名: 泌尿器科紀要
巻: 31
号: 11
開始ページ: 2090
終了ページ: 2104
抄録: 淋菌性感染症244例(男子尿道炎212例, 女子子宮頸管炎32例)に対し, Aztreonam one shot (1~2 g)治療を試みた.1)症例より分離した淋菌244株中42株(17.2%)がPPNGであった.2) Aztreonamの淋菌に対する106 CFU/mlでのMICはβ-lactamase産生に関係なく, 0.025 μg/mlにpeakをもち, 0.0125 μg/ml以下から0.2 μg/mlに分布していた.3) Aztreonam 1 gおよび2 g投与による淋菌の消失時間は1~8時間, 平均4~4.5時間の間に消失をみており, 1 gと2 gの間にほとんど差は認められなかった.4) Aztreonam 1 g one shot, 2 g one shotによる臨床効果を男女244例について検討したが, 3日所見で判定するとPPNGでも治療効果は変らず, 有効率は男子尿道炎では1 g 90.7%, 2 g 97.1%, 女子子宮頸管炎では1 g, 2 gとも100%であった.5) Aztreonamの副作用は244例中しびれ, 両手に発赤, 腫脹1例, 倦怠感1例の計2例(0.8%)にみられたがいずれも軽度であった
A clinical study of a new monocyclic beta-lactam antibiotic, AZTREONAM (hereafter referred to as AZT) for gonorrheal infections as well as epidemiologic study of gonorrheal infections were made Epidemiology: There was a reflection of the increasing sexual activity of the younger generation; both male and female patients in their twenties were most frequent (male 49.5%, female 43.7%) and the percent of teen age patients was 15.1% (male) and 34.4% (female). Forty two strains (17.2%) out of 244 clinically isolated gonococci were PPNG. Residue of serious secretion was observed in a little less than 20% suggesting a complication by Chlamydia trachomatis. Clinical Result: One shot (1-2 g) therapy by AZT was given to 244 gonorrheal infection cases (212 urethritis cases of males. 32 cervicitis cases of females) with the following highly effective rate. Although beta-lactamase producing MIC of AZT at 10(6) CFU/ml showed a peak of 0.025 microgram/ml and ranged between less than 0.0125 microgram/ml to 0.2 microgram/ml. The time required for the elimination of gonococci was studied by the administration of 1 g and 2 g AZT. Gonococci became extinct in 1-8 hours or 4-4.5 hours on average. The difference between n 1 g and 2 g was scarcely observed. Clinical effect of 1 g one shot and 2 g one shot AZT was examined on the 3rd treatment day for 244 male and females cases. The effective rate was high; 90.7% by 1 g, 97.1% by 2 g for male urethritis, 100% by 1 g also by 2 g for female cervicitis. This therapeutic efficacy was kept even in PPNG, isolated cases. There were two side effects (0.8%), one case each of numbness and, redness and swelling of both hands, out of 244 cases, but both of them were minor ones without clinical complication.
URI: http://hdl.handle.net/2433/118646
PubMed ID: 3937450
出現コレクション:Vol.31 No.11

アイテムの詳細レコードを表示する

Export to RefWorks


出力フォーマット 


このリポジトリに保管されているアイテムはすべて著作権により保護されています。